Brief: Lansen Pharmaceutical Holdings Posts HY Profit Attributable $10.6 Mln, Down 52.3 Pct
28/08/2018 14:03
Aug 28 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* HY PROFIT ATTRIBUTABLE $10.6 MILLION, DOWN 52.3 PERCENT
* HY REVENUE $35.9 MILLION, DOWN 28.8 PERCENT
* RECOMMENDS PAYMENT OF AN INTERIM DIVIDEND OF HK2.90 CENTS
PER
SHARE
Source text for Eikon: ID:nHKS9Ztm2V
Further company coverage: 0503.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year